Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

MLA

Vesterhus, Mette, et al. “Novel Serum and Bile Protein Markers Predict Primary Sclerosing Cholangitis Disease Severity and Prognosis.” Journal of Hepatology, vol. 66, no. 6, June 2017, pp. 1214–22. EBSCOhost, https://doi.org/10.1016/j.jhep.2017.01.019.

APA

Vesterhus, M., Holm, A., Hov, J. R., Nygård, S., Schrumpf, E., Melum, E., Thorbjørnsen, L. W., Paulsen, V., Lundin, K., Dale, I., Gilja, O. H., Zweers, S. J. L. B., Vatn, M., Schaap, F. G., Jansen, P. L. M., Ueland, T., Røsjø, H., Moum, B., Ponsioen, C. Y., … Lund-Johansen, F. (2017). Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis. Journal of Hepatology, 66(6), 1214–1222. https://doi.org/10.1016/j.jhep.2017.01.019

Chicago

Vesterhus, Mette, Anders Holm, Johannes Roksund Hov, Ståle Nygård, Erik Schrumpf, Espen Melum, Liv Wenche Thorbjørnsen, et al. 2017. “Novel Serum and Bile Protein Markers Predict Primary Sclerosing Cholangitis Disease Severity and Prognosis.” Journal of Hepatology 66 (6): 1214–22. doi:10.1016/j.jhep.2017.01.019.